Results 121 to 130 of about 24,788 (241)

Chronic ulcerative oesophagitis rich in IgG4‐positive plasma cells – a distinct clinicopathological entity

Histopathology, Volume 89, Issue 1, Page 47-57, July 2026.
We report a series of 12 patients (mean age 63 years) with chronic oesophageal ulceration showing morphological features of IgG4‐related inflammatory disease. Most patients underwent several rounds of endoscopy until this association was recognized. The majority of patients went into clinical and histological remission following corticosteroid therapy.
Hanna Henzinger, Ian Brown, Anthony J Gill, Tomas Slavik, Giuseppe Zamboni, Cord Langner   +5 more
wiley   +1 more source

Microscopic colitis and primary sclerosing cholangitis are bidirectionally associated: A nationwide matched cohort and case–control study

Journal of Internal Medicine, Volume 300, Issue 1, Page 78-92, July 2026.
Abstract Background Microscopic colitis (MC) is an inflammatory disease of the colon. Although there is a known association between inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC), evidence linking MC and PSC remains scarce. We aimed to investigate the bidirectional association between MC and PSC.
David Bergman, Anders Forss, Jiangwei Sun, Fahim Ebrahimi, Björn Lindkvist, Charlotte Hedin, Hannes Hagström, Annika Bergquist, Jialu Yao, Jonas F. Ludvigsson   +9 more
wiley   +1 more source

Early initiation of inhaled corticosteroid-long-acting β₂-agonist therapy and reduction of severe asthma exacerbations in high-risk preschool children: A longitudinal real-world cohort study. [PDF]

Pediatr Allergy Immunol
Abstract Background Evidence supporting inhaled corticosteroid plus long‐acting β2‐agonist (ICS + LABA) therapy in preschool children with asthma remains limited, and guideline recommendations remain cautious. However, real‐world effectiveness in high‐risk young children has not been adequately characterized. Objective To evaluate short‐ and long‐term
Owora AH, Jiang B, Shah Y.
europepmc   +2 more sources

Appropriate Medical Therapy Primarily Modifies Type 2 and Severity Biomarkers in Chronic Rhinosinusitis

International Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 595-606, June 2026.
ABSTRACT Background Appropriate medical therapy (AMT) is first‐line treatment for patients with chronic rhinosinusitis (CRS). We evaluated inflammatory structure, treatment‐induced changes, and biomarker‐outcome associations in AMT‐managed patients. Methods Fifty‐one CRS patients were evaluated before and after AMT which included a combination of oral ...
Asher C. Park, Brooke N. Gleason, Eli Stein, Saied Ghadersohi, Atsushi Kato, Stephanie Shintani‐Smith, David B. Conley, Kevin C. Welch, Robert C. Kern, Bruce K. Tan   +9 more
wiley   +1 more source

Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes

Patient Related Outcome Measures, 2011
Richard D O'ConnorSharp Rees-Stealy Medical Group, San Diego, CA, USAAbstract: In the United States, budesonide/formoterol pressurized metered-dose inhaler (pMDI) is approved for treatment of asthma in patients aged ≥12 years whose asthma ...
Richard D O'Connor
doaj  

Mucoadhesive Budesonide Solution for the Treatment of Pediatric Eosinophilic Esophagitis

Pharmaceuticals
Eosinophilic Esophagitis is an antigen-mediated inflammatory disease characterized by thickening of the esophageal wall, leading to dysphagia, vomiting, reflux, and abdominal pain. This disease can be treated with a therapeutic approach ranging from diet
Antonio Spennacchio, Antonio Lopalco, Giuseppe Francesco Racaniello, Annalisa Cutrignelli, Flavia Maria la Forgia, Sergio Fontana, Fernanda Cristofori, Ruggiero Francavilla, Angela Assunta Lopedota, Nunzio Denora   +9 more
doaj   +1 more source

Bronchodilation of formoterol administered with budesonide: Device and formulation effects

, 2008
BACKGROUND: Previous single-dose crossover studies have established therapeutic equivalence of formoterol when administered at the same nominal dose via a dry powder inhaler (DPI) or pressurized hydrofluoroalkane (HFA) metered-dose inhaler (pMDI ...
Mezzanotte, W., Miller, C., Senn, S.
core   +1 more source

Isoniazid‐Related Secondary Drug‐Induced Autoimmune Hepatitis in a Patient Diagnosed With Ankylosing Spondylitis and Tuberculous Lymphadenitis: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Autoimmune hepatitis is a type of chronic hepatitis that is usually progressive, has unknown etiology, and can occur at any age. In the present case, drug‐associated autoimmune hepatitis (DIAIH) was discussed, and DIAIH secondary to isoniazid (INH) was found in two case reports in the literature.
Murat AY, Erhan Bozkurt
wiley   +1 more source

Diagnostic Accuracy of Salivary Periodontal Biomarkers Is Reduced in Patients With Crohn's Disease

Clinical and Experimental Dental Research, Volume 12, Issue 3, June 2026.
ABSTRACT Objectives Patients with Crohn's disease (CD) are at increased risk of developing periodontal disease and may benefit from salivary biomarker–based monitoring for early detection and management. Given the previously reported reduced specificity of the salivary aMMP‐8 test in CD, this study aimed to evaluate alternative salivary biomarkers for ...
Alisa Toivanen, Nur, Ismo Räisänen, Mervi Gürsoy, Ulvi Kahraman Gürsoy, Timo Sorsa, Jaana Rautava   +6 more
wiley   +1 more source

Therapeutic drug monitoring of corticosteroids/β2-agonists in the hair of patients with asthma: an open-label feasibility study

Frontiers in Pharmacology
Background: Although adherence to inhaled medication is critically important for treatment efficiency, around half of patients taking these drugs are non-adherent or make critical errors when using their delivery device.
Hélène Salvator, Hélène Salvator, Hélène Salvator, Elodie Lamy, Camille Roquencourt, Emmanuelle Bardin, Emmanuelle Bardin, Emmanuelle Bardin, Philippe Devillier, Philippe Devillier, Stanislas Grassin-Delyle, Stanislas Grassin-Delyle   +11 more
doaj   +1 more source